PCOS Is Becoming PMOS: What the Name Change Means for Fertility and IVF
by Ermina Konstantinidou, last updated 01 Jun 2026,
10 min read
For decades, polycystic ovarian syndrome, better known as PCOS, has been one of the most common hormonal conditions affecting women of reproductive age. It has also been one of the most misunderstood.
PCOS is now being renamed as PMOS: Polyendocrine Metabolic Ovarian Syndrome.
The change follows an international consensus process, with the new name published in The Lancet and announced by recognised medical bodies including the Endocrine Society. It is not a new disease. PMOS describes the same condition previously known as PCOS, but with a name that better reflects what is really happening in a woman’s body.

For women who have received such a diagnosis, this matters. The old name placed too much emphasis on “cysts” and the ovaries. PMOS recognizes that the condition can involve multiple hormonal systems, metabolic health, ovulation, menstrual cycles, insulin-related pathways, skin, hair growth, long-term health, and fertility.
At our clinic, we welcome this change because it supports the way fertility care should be delivered: with accurate diagnosis, individualised treatment, and attention to the full reproductive and metabolic picture.
PCOS or PMOS: which name should patients use?
During the transition period, patients are likely to see both names used: PCOS and PMOS.
This is expected. The move from PCOS to PMOS will take time to appear across guidelines, laboratory systems, medical records, websites, patient leaflets, and everyday clinical conversations. For now, many clinics and healthcare professionals may use both terms together.
If you have previously been diagnosed with PCOS, your diagnosis has not disappeared. PMOS is a more accurate name for the same condition.
Why was the name PCOS misleading?
The term “polycystic ovarian syndrome” often caused unnecessary confusion. Many women hear the word “cystic” and worry that they have dangerous ovarian cysts. In reality, the small fluid-filled structures often seen on ultrasound are usually follicles, small sacs that contain immature eggs. They are not the same as abnormal ovarian cysts that may need separate treatment.
The old name also made the condition sound mainly gynaecological. But PCOS/PMOS is broader than the ovaries. It may involve reproductive hormones, androgen levels, ovulation, insulin function, blood sugar regulation, weight-related factors, and long-term metabolic health.
The new name, Polyendocrine Metabolic Ovarian Syndrome, reflects this more accurately:
- Polyendocrine means that more than one hormonal system may be involved.
- Metabolic recognises the role of insulin resistance, blood sugar regulation, weight-related factors, and long-term health risks.
- Ovarian keeps the reproductive aspect in focus, because the condition can affect ovulation, egg release, menstrual regularity, and fertility.
Common symptoms of PMOS
PMOS can look different from one woman to another. Some women have irregular periods. Others notice acne, excess facial or body hair growth, or scalp hair thinning. Some are diagnosed only when they start trying to conceive.
Common features may include:
- Irregular, infrequent, or absent periods
- Not regular ovulations
- Fertility issues
- Acne
- Excess facial or body hair growth
- Scalp hair thinning
- Weight changes or difficulties regulating weight
- Insulin resistance or other metabolic features
- Polycystic ovarian appearance on ultrasound
- Higher androgen levels on blood tests
Not every woman has every symptom. PMOS can occur in women of different body weights, and ultrasound findings alone are not enough to understand the full condition.
This is why proper assessment matters.
How is PMOS diagnosed?
Diagnosis should be based on a structured clinical assessment, not on one symptom or one scan.
The 2023 International Evidence-Based Guideline for PCOS describes diagnosis using key features such as ovulatory dysfunction, clinical or biochemical signs of androgen excess, and polycystic ovarian morphology, after excluding other conditions where appropriate.
In practice, this means your doctor may assess:
- Menstrual cycle pattern
- Ovulation history
- Acne, hair growth, or hair thinning
- Pelvic ultrasound findings
- Reproductive hormone levels
- Androgen levels
- AMH or ovarian reserve assessment, where appropriate
- Blood glucose, HbA1c, lipid profile, or an oral glucose tolerance test where indicated
- Thyroid and prolactin levels when relevant
- Other possible causes of irregular cycles or androgen excess
For fertility patients, assessment should also include the wider fertility picture, such as fallopian tube status where necessary and semen analysis for the male partner where applicable. PMOS may be one factor, but it may not be the only one. A complete evaluation helps avoid delay and allows treatment to be planned correctly from the beginning.
PMOS and fertility: why ovulation matters
One of the main ways PMOS affects fertility is by disrupting ovulation. To conceive naturally, an egg usually needs to mature and be released from the ovary. In PMOS, ovulation may happen irregularly or not at all. This can lead to long cycles, unpredictable fertile windows, or months without ovulation.
However, PMOS does not mean pregnancy is impossible. Many women with PMOS conceive naturally. Others conceive with ovulation induction, intrauterine insemination, or IVF.
The first step: a complete fertility assessment
If you have PCOS/PMOS and are trying to conceive, the first step is a structured fertility assessment.
This may include:
- Detailed menstrual and medical history
- Pelvic ultrasound
- Hormonal blood tests
- Androgen assessment
- Ovarian reserve testing where appropriate
- Blood glucose, HbA1c, lipid profile, or oral glucose tolerance test where indicated
- Thyroid and prolactin testing when relevant
- Fallopian tube assessment where clinically necessary
- Semen analysis for the male partner, where applicable
This helps identify whether the main issue is ovulation, whether other fertility factors are present, and which treatment is most likely to help. At our clinic, we use this information to recommend a treatment plan that fits your individual situation, rather than treating PMOS as a single standard diagnosis.
Ovulation induction: helping the ovary release an egg
For many women with PMOS-related anovulation, treatment may begin with ovulation induction. Ovulation induction uses medication to help the ovary develop and release an egg. This is commonly done with medicines such as letrozole, where appropriate. In selected patients, ovulation induction may be combined with timed intercourse or intrauterine insemination.
The aim is safe, controlled ovulation, ideally with one mature follicle. Ultrasound monitoring and, when needed, hormone testing help assess response and reduce the risk of multiple pregnancy or ovarian over-response.
For some women, ovulation induction is enough to achieve pregnancy. For others, IVF may be the more appropriate next step.
When IVF may be recommended
IVF may be recommended for women with PMOS when:
- Ovulation induction has not resulted in pregnancy
- There are additional fertility factors
- There is male-factor infertility
- The fallopian tubes are blocked or damaged
- Age makes a faster treatment pathway advisable
- Previous fertility treatments have been unsuccessful
- Embryo testing is needed in selected cases
- IVF offers the most appropriate chance based on the full assessment
The decision to move to IVF should not be based on the PMOS diagnosis alone. It should be based on your age, ovarian reserve, fertility history, partner results, medical profile, and personal goals.
PMOS and IVF: why protocol choice matters
Women with PMOS can respond strongly to ovarian stimulation medication during IVF. This can be positive because it may result in a good number of eggs, but it also requires careful planning.
One of the main risks in IVF for women with PMOS is the ovarian hyperstimulation syndrome, known as OHSS. OHSS can occur when the ovaries over-respond to stimulation. Modern IVF protocols can reduce this risk significantly, but treatment must be tailored.
At our clinic, IVF planning for women with PCOS/PMOS may include:
- An individualised starting dose of stimulation medication
- Close ultrasound and blood monitoring
- Finding a suitable stimulation protocol (e.g. antagonist, PPOS)
- Trigger medication selected to reduce OHSS risk
- Careful planning of fresh versus frozen embryo transfer
- Review of metabolic health before treatment
- Personalised luteal phase and embryo transfer support
PMOS is not a reason to fear IVF. It is a reason to choose a fertility team experienced in managing ovarian response safely and precisely.
Does PMOS affect egg quality?
PMOS does not automatically mean poor egg quality. Egg quality is mainly related to reproductive age.
Many women with PMOS produce a good number of eggs and can have good IVF outcomes when treatment is well managed. The more useful question is not simply whether PMOS affects egg quality, but what the overall reproductive environment looks like.
The role of metabolic health before fertility treatment
The word “metabolic” in PMOS is important.
Insulin resistance and blood sugar regulation can influence androgen levels, ovulation, cycle regularity, and pregnancy health. For some women, addressing metabolic health before or alongside fertility treatment may support better reproductive outcomes.
This does not mean blaming women for their condition. PMOS is not a lifestyle failure. It is a complex hormonal and metabolic syndrome influenced by biology, genetics, and individual health factors. Depending on your needs, preparation may include:
- Nutrition support
- Exercise guidance
- Weight management where medically appropriate
- Screening for blood sugar and lipid abnormalities
- Medication when clinically indicated
- Vitamin and micronutrient assessment where relevant
The goal is preparation, not perfection: helping your body enter fertility treatment, implantation, and pregnancy in the best possible condition.
Why choose specialist fertility care for PMOS?
PMOS can be frustrating because it does not always follow a predictable pattern. Some women ovulate occasionally. Some respond strongly to medication. Some have metabolic factors that need attention. Some have additional fertility issues that only become clear after proper investigation. This is where specialist fertility care can make a real difference.
At our clinic, we assess your hormones, ovulation, ovarian reserve, metabolic health, ultrasound findings, partner factors, and treatment history before recommending a plan.
Our aim is to help you understand:
- What may be affecting your fertility
- Whether you are ovulating
- Which treatment options are suitable
- Whether ovulation induction, IUI, or IVF is most appropriate
- How to reduce risks such as over-response during IVF
- What can be addressed before treatment begins
- How to move forward with confidence
- PMOS is complex, but your treatment pathway should be clear.
Moving forward: better language, better fertility care
The change from PCOS to PMOS is an important step forward in women’s health. It recognises that this condition is not simply about ovarian cysts. It is a hormonal, metabolic, and reproductive condition that deserves proper investigation and individualised care.
For patients, the new name may feel validating. It helps explain why symptoms can affect periods, skin, hair growth, weight, blood sugar, ovulation, and fertility. For clinicians, it is a reminder to look beyond the ultrasound and treat the full condition.
If you have been diagnosed with PCOS, are hearing the term PMOS for the first time, or are trying to conceive with irregular cycles, we are here to help. At our clinic, we provide personalised fertility assessment and treatment for women with PCOS/PMOS, including ovulation induction, IVF planning, metabolic review, and carefully tailored stimulation protocols.
If you are trying to conceive, preparing for IVF, or wondering how PCOS/PMOS may affect your fertility, book a free medical consultation with our team. A personalised assessment can help you understand your diagnosis, your options, and the safest next step toward pregnancy.
Ermina Konstantinidou, BSc, MSc
Ermina is a Midwife and an International Patient Coordinator at Newlife IVF Greece.